{
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1118, 
        1141
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        936, 
        956
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        845, 
        872
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        643, 
        678
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        733, 
        759
      ]
    }
  ], 
  "Specimen Tissue/Substance (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        761, 
        781
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1053014^CLIA|eMARCPlus|TN Cancer Registry|20170929000225||ORU^R01^ORU_R01|201709290002250001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-CY-001657^PathSys^44D1053014^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170918000000|||||||20170918000000|&Body Cav Fluid Cyto, Liquid based preparation tech|1548227416^ ^^^^^MD^^CMS^D^^^NPI||||||20170919000000|||F||||||C18.0^Malignant neoplasm of cecum^I10~C79.62^Secondary malignant neoplasm of left ovary^I10~C77.2^Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes^I10|1083715031&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.microscopic examination\n\nThinPrep and cell block preparations are examined.\n\n\nPath report.site of origin\n\nAscites/Pelvic Fluid  10 mls red cloudy fluid received with 5000 units of Heparin\n\n\nPath report.final diagnosis\n\nPelvis, washing:   Reactive mesothelial cells. See comment.\n\n\nPath report.comments\n\nComments - The cytologic specimen is negative for atypical proliferation and malignant neoplasm. Please refer to the concurrent surgical specimen, 17-21-9394\n\n\nPath report.relevant Hx\n\nHistory - Pelvic abdominal mass\n\n\n"
}